News from the healthcare data industry
ELMWOOD PARK, N.J., Nov. 28, 2023 /PRNewswire/ — BioReference® Health, LLC (BRH), a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a pioneer in providing accessible, quality real world data (“RWD”) for the pharmaceutical and life science industries. This collaborative arrangement will offer healthcare providers and researchers unique…
November 28, 2023 04:15 PM Eastern Standard Time FREMONT, Calif. & CHICAGO–(BUSINESS WIRE)–Personalis, Inc., a leader in advanced genomics for precision oncology (Nasdaq: PSNL), and Tempus Labs, Inc., a leader in artificial intelligence and precision medicine, today announced a strategic collaboration to co-commercialize NeXT Personal® Dx, Personalis’ whole genome-based liquid biopsy laboratory…
In the first comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data, Truveta Research found that patients with overweight or obesity taking tirzepatide were three times more likely to achieve 15% weight loss than those taking semaglutide (Ozempic). November 27, 2023 09:00 ET| Source:Â Truveta…
Flywheel announces the launch of its SaaS data management solution on Microsoft Azure, integrated with NVIDIA MONAI. Flywheel users will also be able to utilize radiology reports with mPower Clinical Analytics by Nuance, a Microsoft company. (Graphic: Flywheel) November 22, 2023 09:00 AM Eastern Standard Time MINNEAPOLIS–(BUSINESS WIRE)–Flywheel, a leading…
November 21, 2023 Awards support 26 two-year projects on a broad range of disease areas funded across NIH The National Institutes of Health’s All of Us Research Program and 10 partner Institutes, Centers, and Offices have funded 26 research projects to support novel analyses and tool development using All of Us’ data. The two-year…
November 20, 2023 12:00 PM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx to be used as a companion diagnostic for AstraZeneca’s Truqap™ (capivasertib) in combination with Faslodex® (fulvestrant) which has been contemporaneously approved for the…
New solutions empower clinicians and research teams with AI orchestration, model development, visualization, and multi-modal data management to power clinical research, clinical trials, and patient care strategies. CAMBRIDGE, Mass., Nov. 20, 2023 /PRNewswire/ — ConcertAI’s TeraRecon, the advanced visualization and clinical AI leader, recently unveiled first-in-category capabilities in advanced visualization, AI, and expansions to…
Tempus, a leader in artificial intelligence and precision medicine, today announced that City of Hope Comprehensive Cancer Center has joined Tempus+, a proprietary program that powers collaborative precision oncology research through the use of real-world data. The Tempus+ community of researchers represents over 30 medical centers that are leveraging the program…
The NeuroBlu Database is now the largest NLP-enriched, de-identified real-world data platform designed for behavioral and mental health NEW YORK, Nov. 16, 2023 /PRNewswire/ — Holmusk, a leading global behavioral health real-world evidence company, today announced that NeuroBlu has reached a major growth milestone of over 4 million patient lives, making it…
Cambridge, Mass., & Castres, France – Foundation Medicine, Inc., and Pierre Fabre Laboratories today announced a collaboration to develop Foundation Medicine’s high-quality genomic tests, FoundationOne®CDx and FoundationOne®Liquid CDx, as companion diagnostics for new targeted therapies to treat patients with non-small cell lung cancer (NSCLC). The companies will work collaboratively to seek…